Enanta Pharmaceuticals reported $5.9M in Trade Creditors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Amgen AMGN:US $ 1277M 119M
Anika Therapeutics ANIK:US $ 8.1M 0.58M
Arrowhead Research ARWR:US $ 10.04M 4.74M
Biogen BIIB:US $ 375.3M 55.1M
Bristol Myers Squibb BMY:US $ 3609M 637M
Clovis Oncology CLVS:US $ 22.48M 1.98M
Enanta Pharmaceuticals ENTA:US $ 5.9M 0.2M
Halozyme Therapeutics HALO:US $ 4.56M 4.03M
Heron Therapeutics HRTX:US $ 11.24M 9.55M
Insmed INSM:US $ 31.08M 8.66M
Intercept Pharmaceuticals ICPT:US $ 15.09M 2.51M
Karyopharm Therapeutics KPTI:US $ 2.31M 731K
Marinus Pharmaceuticals MRNS:US $ 3.31M 1.86M
Novartis NOVN:VX 4.81B 229M
Novavax NVAX:US $ 74M 39.61M
Ptc Therapeutics PTCT:US $ 20.82M 1.71M
Sarepta Therapeutics SRPT:US $ 76.68M 0.03M
Vertex Pharmaceuticals VRTX:US $ 127.53M 0.3M
Vital Therapies VTL:US $ 4.18M 5.87M
YTE INCY:US $ 122.1M 37.04M